AVLN logo
NASDAQ · AVLNBiotechnologyUpdated Nov 2, 2026

Avalyn Pharma Inc. Common Stock ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Avalyn Pharma Inc. Common Stock (AVLN) is -83.23%

According to Avalyn Pharma Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -83.23%. This represents a change of -5831.03% compared to the average of 1.45% of the last 4 quarters.

Avalyn Pharma Inc. Common Stock (AVLN) Historical ROE (quarterly & annually)

How has AVLN ROE performed in the past?

The mean historical ROE of Avalyn Pharma Inc. Common Stock over the last ten years is 35.70%. The current -83.23% ROE has changed -333.12% with respect to the historical average. Over the past ten years (40 quarters), AVLN's ROE was at its highest in in the March 2026 quarter at 10.17%. The ROE was at its lowest in in the June 2026 quarter at -7.26%.

Quarterly (TTM)
Annual

Average

35.70%

Median

35.70%

Minimum

35.70%

Maximum

35.70%

Avalyn Pharma Inc. Common Stock (AVLN) ROE by Quarter and Year

Discovering the peaks and valleys of Avalyn Pharma Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 35.70%

Minimum Annual Increase = 0%

Minimum Annual ROE = 35.70%

Quarterly (TTM)
Annual
YearROEChange

Avalyn Pharma Inc. Common Stock (AVLN) Average ROE

How has AVLN ROE performed in the past?

The current ROE of Avalyn Pharma Inc. Common Stock (AVLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

35.70%

5-year avg

35.70%

10-year avg

35.70%

Avalyn Pharma Inc. Common Stock (AVLN) ROE vs. Peers

How is AVLN’s ROE compared to its peers?

Avalyn Pharma Inc. Common Stock’s ROE is greater than Vicore Pharma Holding AB (-53.71%), greater than Insmed Incorporated (-82.75%), greater than Gyre Therapeutics, Inc. (-15.77%), greater than Pulmatrix, Inc. (-109.26%), less than MannKind Corporation (78.60%),

Build a custom stock screener for Avalyn Pharma Inc. Common Stock (AVLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avalyn Pharma Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avalyn Pharma Inc. Common Stock (AVLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avalyn Pharma Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Avalyn Pharma Inc. Common Stock's ROE?

How is the ROE calculated for Avalyn Pharma Inc. Common Stock (AVLN)?

What is the highest ROE for Avalyn Pharma Inc. Common Stock (AVLN)?

What is the 3-year average ROE for Avalyn Pharma Inc. Common Stock (AVLN)?

What is the 5-year average ROE for Avalyn Pharma Inc. Common Stock (AVLN)?

How does the current ROE for Avalyn Pharma Inc. Common Stock (AVLN) compare to its historical average?